| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 06/30/2005 | WO2004085388A3 Cyclic protein tyrosine kinase inhibitors |
| 06/30/2005 | WO2002058698A8 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 06/30/2005 | US20050143426 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 06/30/2005 | US20050143418 Pesticidal heterocycles |
| 06/30/2005 | US20050143405 Dipeptidyl peptidase inhibitors that lower plasma glucose; treatment and prophylaxis of diabetes, non-insulin dependent diabetes; 2-amino-3aminomethyl-4-phenylpyridines |
| 06/30/2005 | US20050143401 Anticancer agents; (4-(3-Fluorobenzyloxy)-3-chlorophenyl)-(6-(2-((2-methanesulphonyl-ethylamino)ethyl)-thiazol-4-yl)-quinazolin-4-yl)-amine |
| 06/30/2005 | US20050143387 Preserving cosmetic, household or technical products, use in paper treatment liquors, printing thickeners, printing thickeners of starch or cellulose derivatives and paints |
| 06/30/2005 | US20050143385 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors |
| 06/30/2005 | US20050143368 Chemical compounds |
| 06/30/2005 | CA2550168A1 Substituted 8'-pyri(mi)dinyl-dihydrospiro-[cycloalkylamine]-pyrimido[1,2-.alpha.]pyrimidin-6-one derivatives |
| 06/30/2005 | CA2549660A1 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | CA2548388A1 Heterocyclic aspartyl protease inhibitors |
| 06/29/2005 | EP1547597A2 Use of adatanserin for the treatment of neurodegenerative conditions |
| 06/29/2005 | EP1546371A1 Substrates for o6-alkylguanine-dna alkyltransferase |
| 06/29/2005 | EP1546119A1 Process for the preparation of 4- (3'chloro-4'-fluoroanilino) -7-methoxy-6- (3-morpholinopropoxy) quinazoline |
| 06/29/2005 | EP1546117A2 Protein kinase inhibitors and uses thereof |
| 06/29/2005 | EP1546116A1 Vanilloid receptor ligands and their use in treatments |
| 06/29/2005 | EP1546115A2 Substituted pyrimidines |
| 06/29/2005 | EP1546114A1 Tetrahydropyrimidine-2-one derivatives and their uses |
| 06/29/2005 | EP1546113A1 Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes |
| 06/29/2005 | EP1546112A2 Imidazolopyridines and methods of making and using the same |
| 06/29/2005 | EP1546089A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 06/29/2005 | EP1545538A2 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 06/29/2005 | EP1315727B1 7-oxo pyridopyrimidines |
| 06/29/2005 | EP1315473B1 Use of ectoine or ectoine derivatives for oral care |
| 06/29/2005 | EP1021186B1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IkappaB-alpha |
| 06/29/2005 | CN1633431A 喹唑啉衍生物类激酶抑制剂 Quinazoline derivatives kinase inhibitors |
| 06/29/2005 | CN1633426A 1, 3-dihydroxy benzene derivatives and coloring agent containing the same |
| 06/29/2005 | CN1633419A CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 06/29/2005 | CN1633418A Arylalkane-sulfonamides having endothelin-antagonist activity |
| 06/29/2005 | CN1633296A Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/29/2005 | CN1631882A Preparation method of agricultural fungicide N-(4, 6-dimethyl pyrimidine-2-yl) aniline |
| 06/29/2005 | CN1208329C Aniline derivatives |
| 06/29/2005 | CN1208326C Heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| 06/29/2005 | CN1208325C 2-pyrimidine oxy-N-ureido phenyl-benzyl amide compound, preparing method and use thereof |
| 06/29/2005 | CN1208321C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 06/28/2005 | US6911469 For therapy of disease treatable based on a blood sugar level-depressing activity or a disease treatable based on a cGMP-PDE inhibiting activity, smooth muscle relaxing activity, bronchodilating activity, vasodilating activity |
| 06/28/2005 | US6911450 Pyrimidine acyclonucleoside derivatives, preparation method and use thereof |
| 06/28/2005 | US6911446 Methods of modulating serine/threonine protein kinase function with quinazoline-based compounds |
| 06/28/2005 | US6911439 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents |
| 06/28/2005 | US6911433 O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates |
| 06/28/2005 | US6911424 2′-fluoronucleosides |
| 06/23/2005 | WO2005056536A1 Antidiabetic agents which exhibit activity against ppar |
| 06/23/2005 | WO2005056534A1 Reference standard for characterization of rosuvastatin |
| 06/23/2005 | WO2005056528A1 Carboxamide derivatives |
| 06/23/2005 | WO2005055715A2 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives |
| 06/23/2005 | WO2005040129A3 Ccr3 receptor antagonists |
| 06/23/2005 | WO2005040121A3 Amides that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 06/23/2005 | WO2005025555A3 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid |
| 06/23/2005 | WO2005000406A3 Treatment of amyloid- and epileptogenesis-associated diseases |
| 06/23/2005 | US20050137216 Heterocyclic sodium/proton exchange inhibitors and method |
| 06/23/2005 | US20050137213 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis; antiproliferative, anticarcinogenic, antimetabolic agents; tubulin and topoisomerase II inhibitors; fungicides; synergistic administration with other anticarcinogenic agents |
| 06/23/2005 | US20050137212 Hppars activators |
| 06/23/2005 | US20050137190 Compositions useful as inhibitors of voltage-gated sodium channels |
| 06/23/2005 | DE10249946B4 Verfahren zur Herstellung von 2-Amino-4-chlor-6-alkoxypyrimidinen A process for the preparation of 2-amino-4-chloro-6-alkoxypyrimidinen |
| 06/23/2005 | CA2549548A1 Carboxamide derivatives |
| 06/23/2005 | CA2548516A1 Pyrazolopyrimidines |
| 06/22/2005 | EP1542992A2 Process for preparing quinazoline rho-kinase inhibitors and intermediates thereof |
| 06/22/2005 | EP1542991A1 Pyrimidine compounds as therapeutic agents |
| 06/22/2005 | EP1542978A1 Novel bio-active molecules |
| 06/22/2005 | EP1542694A1 New spirocondensed quinazolinones and their use as phosphodiesterase inhibitors |
| 06/22/2005 | EP1542692A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 06/22/2005 | EP1317434A4 Preparation of risperidone |
| 06/22/2005 | EP1154774B1 Quinazoline derivatives as angiogenesis inhibitors |
| 06/22/2005 | CN1630645A 5-HT receptor ligands and uses thereof |
| 06/22/2005 | CN1630644A Pyridine and pyrimidine derivatives |
| 06/22/2005 | CN1630643A Substituted benzoylcyclohexane diones for use as herbicides |
| 06/22/2005 | CN1630637A Novel arylheteroalkylamine derivatives |
| 06/22/2005 | CN1630633A N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
| 06/22/2005 | CN1630632A Aromatic amino acid derivates and medicinal compositions |
| 06/22/2005 | CN1630520A Use of rosuvastatin (ZD-4522) in the treatment of heterozygous familial hypercholesterolemia |
| 06/22/2005 | CN1207288C Retroviral protease inhibiting compounds |
| 06/22/2005 | CN1207056C Peptide-containing & alpha; -ketoamide cysteine and serine protease inhibitors |
| 06/22/2005 | CN1206914C Pesticide containing 0-benzyl oximeether derivative and its use |
| 06/21/2005 | US6908948 Saturated nitrogen compounds, that bind to nucleic acids and generate chemical intermediates that splice the strands; prophylaxis of tumors and viral diseases |
| 06/21/2005 | US6908935 Calcium receptor modulating agents |
| 06/21/2005 | US6908920 Pyrimidine derivatives |
| 06/16/2005 | WO2005054208A1 Method for producing 3-phenyl(thio)uracils and 3-phenyldithiouracils |
| 06/16/2005 | WO2005054207A1 Process for the preparation of pyrimidine derivatives |
| 06/16/2005 | WO2005054199A1 Tubulin inhibitors |
| 06/16/2005 | WO2005025293A3 Fused ring heterocycles as potassium channel modulators |
| 06/16/2005 | WO2005023778A3 Process for preparation of rosuvastatin calcium |
| 06/16/2005 | US20050131226 Rearranged pentanols, a process for their production and their use as anti-inflammatory agents |
| 06/16/2005 | US20050131066 Crystalline ammonium salts of rosuvastatin |
| 06/16/2005 | US20050131034 Moderator neurotransmitter release; central nervous ystem disorders ; using a N-methyl-5-(pyrimidyl or pyridyl)-4-penten-2-amine |
| 06/16/2005 | US20050131018 Acetylene derivatives as inhibitors of histone deacetylase |
| 06/16/2005 | US20050130999 Heteroaryl compounds which inhibit leukocyte adhesion mediated by alpha-4 integrins |
| 06/16/2005 | US20050130997 Pyrimidinone viral polymerase inhibitors |
| 06/16/2005 | US20050130996 5-(4-{3-chloro-4-(3-fluorobenzyloxy)-anilino}-6-quinazolinyl)-furan-2-carbaldehyde; selective inhibition of the protein tyrosine kinase activity, minimising side effects |
| 06/16/2005 | US20050130995 Chlorinating quinazolin-4-one in solvent in presence of a base; then reacting with an amine compound |
| 06/16/2005 | US20050130991 Cosmetic and pharmaceutical mixture of enzyme inhibitors, anti microbial agents, anti inflammatory agents, fillers, pigments, antioxidants, preservatives, fragrances, electrolytes, neutralizers, film-forming polymers, UV blockers; hair growth |
| 06/16/2005 | US20050130982 4-isopropyl-2-methoxy-7-[4-(2-pyrimidyl)piperazinomethyl]-2,4,6-cycloheptatrien-1-one |
| 06/16/2005 | US20050130979 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) or the quinoxalinedione is 9-methyl-amino-6-nitro-hexahydro-benzo(F) quinoxalinedione (PNQX) for treating demyelinating disorders |
| 06/16/2005 | US20050130976 Bicyclic inhibitors of MEK and methods of use thereof |
| 06/16/2005 | US20050130973 3-Methyl-2-[4'-(pyridin-3-ylmethoxymethyl)-biphenyl-4-sulfonylamino]-butyric acid; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis |
| 06/16/2005 | US20050130967 3-Substituted-4-pyrimidone derivatives |
| 06/16/2005 | US20050130943 Bicyclic inhibitors of MEK and methods of use thereof |
| 06/16/2005 | DE4217248B4 Vinylverbindungen Vinyl compounds |
| 06/16/2005 | DE10349423A1 Sulfoximinsubstituierte Parimidine als CDK- und/oder VEGF-Inhibitoren, deren Herstellung und Verwendung als Arzneimittel Sulfoximinsubstituierte Parimidine as CDK and / or VEGF inhibitors, their preparation and use as medicaments |
| 06/16/2005 | CA2857067A1 Tubulin inhibitors |